Protagenic Therapeutics Stock (NASDAQ: PTIXW) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 9.01K |
Day Range | - - - |
52 Wk Range | 0.00 - 0.04 |
Market Cap | - |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protagenic Therapeutics (NASDAQ:PTIXW) through any online brokerage.
Other companies in Protagenic Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
There is no analysis for Protagenic Therapeutics.
There is no analysis for Protagenic Therapeutics to provide a consensus price target.
The stock price for Protagenic Therapeutics (NASDAQ: PTIXW) is $0.04 last updated May 31, 2024 at 8:19 AM EDT.
There are no upcoming dividends for Protagenic Therapeutics.
Protagenic Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protagenic Therapeutics.
Protagenic Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.